Total Funding
49
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
291158
iCardiac Technologies is a laboratory that develops cardiac safety biomarkers which provide assessments of drugs in development.
Acquired by 
ERT Clinical
Borje Darpo: Global Medical Director
About the Company
iCardiac Technologies, Inc. develops cardiac safety biomarkers. The company offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers that delivers assessment of the cardiac safety profile of drugs in development. Its technology is used in cardiac clinical trials conducted by pharmaceutical, biotechnology, and medical device companies.
The company’s services include scientific and medical consultation, study design, data and project management, ECG analysis, statistical reporting, data submission, and interface with the regulators. iCardiac Technologies, Inc. was founded in 2006 and is headquartered in Rochester, New York.
Women Founded
